Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis

基岩 医学 队列 肺结核 内科学 养生 入射(几何) 队列研究 不利影响 置信区间 结核分枝杆菌 病理 物理 光学
作者
Syeda Hoorulain Ahmed,Hoorain Haider,Abdul Moeed,A. H. Mahmood,Nasir Shivani,Syed Hasan Shuja,Javeria Hayat,Bushra Jamil,Razia Fatima
出处
期刊:The Indian journal of tuberculosis [Elsevier BV]
卷期号:71 (1): 79-88 被引量:5
标识
DOI:10.1016/j.ijtb.2023.05.005
摘要

Multi and extensively drug-resistant tuberculosis is a grave cause of global public health concern due to its high mortality and limited treatment options. We conducted this systemic review and meta-analysis to evaluate the efficacy and safety of bedaquiline and delamanid, which have been added to the WHO-recommended regimen for treating drug-resistant tuberculosis. Electronic databases were searched from their inception until December 1st, 2021, for eligible studies assessing the efficacy and safety of bedaquiline and delamanid for treating drug-resistant tuberculosis. Binary outcomes were pooled using a DerSimonian-Laird random-effects model and arcsine transformation and reported on a log scale with a 95% confidence interval (CIs). Twenty-one studies were shortlisted in which bedaquiline, delamanid, and a combination of both were administered in 2477, 937, and 169 patients. Pooled culture conversion at 6 months was 0.801 (p < 0.001), 0.849 (p = 0.059) for bedaquiline and delamanid, respectively, and 0.823 (p = 0.017), concomitantly. In the bedaquiline cohort, the pooled proportion of all-cause mortality at 6 months was reported as 0.074 (p < 0.001), 0.031 (p = 0.372) in the delamanid cohort, and 0.172 in the combined cohort. The incidence of adverse events in the bedaquiline cohort ranged from 11.1% to 95.2%, from 13.2% to 86.2% in the delamanid cohort, and 92.5% in a study in the combined cohort. The incidence of QTC prolongation reported in each cohort is as follows: bedaquiline 0.163 (p < 0.001), delamanid 0.344 (p = 0.272) and combined 0.340 (p < 0.001). Our review establishes the efficacy of delamanid, bedaquiline, and their combined use in treating drug-resistant tuberculosis with reasonable rates of culture conversion, low mortality rates, and safety of co-administration, as seen with their effect on the QTc interval.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ing发布了新的文献求助10
1秒前
1秒前
所所应助落寞之云采纳,获得10
2秒前
2秒前
BU会完成签到,获得积分10
2秒前
3秒前
3秒前
3秒前
兔年吉祥完成签到,获得积分20
4秒前
4秒前
充电宝应助高序采纳,获得10
4秒前
Akim应助勤劳代亦采纳,获得10
4秒前
丁仪完成签到,获得积分10
5秒前
5秒前
NexusExplorer应助大力的水风采纳,获得10
6秒前
6秒前
6秒前
中宝发布了新的文献求助10
6秒前
6秒前
Ava应助Ing采纳,获得10
6秒前
6秒前
7秒前
樱悼柳雪发布了新的文献求助10
7秒前
8秒前
stefan发布了新的文献求助10
8秒前
大傻春发布了新的文献求助10
8秒前
852应助亮亮采纳,获得10
8秒前
9秒前
9秒前
fff发布了新的文献求助10
9秒前
庞鲂发布了新的文献求助30
9秒前
勤劳的老九应助兔年吉祥采纳,获得10
10秒前
量子星尘发布了新的文献求助10
10秒前
10秒前
sofar完成签到 ,获得积分10
10秒前
10秒前
11秒前
小马甲应助sup采纳,获得10
11秒前
yyyyyyy111发布了新的文献求助10
11秒前
现代的小馒头完成签到,获得积分10
11秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974844
求助须知:如何正确求助?哪些是违规求助? 3519270
关于积分的说明 11197844
捐赠科研通 3255496
什么是DOI,文献DOI怎么找? 1797791
邀请新用户注册赠送积分活动 877187
科研通“疑难数据库(出版商)”最低求助积分说明 806202